Inaugural Pershing Square Sohn Prize Dinner
The Pershing Square Sohn Cancer Research Alliance celebrated its inaugural dinner and awarding the Pershing Square Sohn Prize to six young, innovative scientists in New York City for cancer research.
News
‘Philanthropy is No Substitute for Government Funding’
By Teresa Tritch (The New York Times) – There has been an upsurge in philanthropy for scientific research by America’s billionaires. As documented by William J. Broad in a recent report for The Times, the sums are huge; the quests serious; the results impressive. Still, in size and scope, philanthropy pales in comparison to public … Continued
Billionaires With Big Ideas Are Privatizing American Science
By William J. Broad (The New York Times) – Funding the Future – As government financing of basic science research has plunged, private donors have filled the void, raising questions about the future of research for the public good.
How to Reverse the Graying of Scientific Research
Dramatically fewer grants are going to young scientists. That’s a cause for alarm. By Ronald J. Daniels and Paul Rothman (The Wall Street Journal) – Youth will be served, as the saying goes, but increasingly that’s not the case in scientific research. The National Institutes of Health reports that between 1980 and 2012, the share … Continued
Cancer Immunotherapy Treatment Shows More Promise
Treatment Eradicated Tumors in 14 of 16 Patients With Advanced Leukemia in Study By Ron Winslow (The Wall Street Journal) – A technique to genetically modify a patient’s own immune cells eradicated tumors in 14 of 16 patients with advanced leukemia—at least for a time—in a study that adds to growing enthusiasm for efforts to … Continued
Immunotherapy: The New Promise for Cancer
By Lauren Pecorino, PhD (The Huffington Post) – I may have written my book Why Millions Survive Cancer: The Successes of Science a little too early. In this book I compiled evidence that progress was being made in the field of cancer.
An Unusual Partnership to Tackle Stubborn Diseases
By Gina Kolata (The New York Times) – The National Institutes of Health, 10 large drug companies and seven nonprofit organizations announced an unconventional partnership on Tuesday intended to speed up development of drugs to treat Alzheimer’s disease, Type 2 diabetes, rheumatoid arthritis and lupus.
Scientists hail breakthrough in embryonic-like stem cells
(Reuters) – In experiments that could open a new era in stem cell biology, scientists have found a simple way to reprogram mature animal cells back into an embryonic-like state that allows them to generate many types of tissue.
Cancer Fight Steps Up in New York City
By Melanie Grayce West (The Wall Street Journal) – An influx of donations this month to support cancer research is positioning New York as a premier location for scientists at a time when major advances are happening in cancer treatment, but fewer public resources are available to study the deadly disease. Read the full article.
Budget Woes, Sequester Place Researchers in a Bind – Young Researchers Hard Hit
(JAMA) – With 14 000 federal scientists returning to the National Institutes of Health (NIH) to salvage research disrupted by the recent government shutdown, they and their academic colleagues face new uncertainties surrounding whether Congress will reach a budget compromise and whether sequester cuts will continue.